BioPharma Dive 2026-02-04 Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions
BioPharma Dive 2026-02-04 Lilly soars again as fast-selling weight loss drugs top Wall Street projections
BioPharma Dive 2026-02-04 Earnings roundup: Amgen vs. FDA, Pfizer’s defense and Merck’s $70B-in-sales plan
BioPharma Dive 2026-02-02 Building a robust in-process testing plan for cell therapy manufacturing success
BioPharma Dive 2026-01-30 AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC
BioPharma Dive 2026-01-28 Lilly bets on Seamless, delving further into genetic medicine for hearing loss